Anke Kretz-Rommel
Hoofd Techniek/Wetenschap/O&O bij Bird Rock Bio, Inc.
Profiel
Anke Kretz-Rommel is currently the Chief Technology Officer at Bird Rock Bio, Inc. Previously, she worked as a Principal at Alexion Antibody Technologies.
She holds a doctorate degree from the Swiss Federal Institute of Technology.
Actieve functies van Anke Kretz-Rommel
| Bedrijven | Functie | Begin |
|---|---|---|
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Hoofd Techniek/Wetenschap/O&O | 27-08-2009 |
Eerdere bekende functies van Anke Kretz-Rommel
| Bedrijven | Functie | Einde |
|---|---|---|
Alexion Antibody Technologies
 Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Corporate Officer/Principal | - |
Opleiding van Anke Kretz-Rommel
| Swiss Federal Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Alexion Antibody Technologies
Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Commercial Services |
